{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:49:28Z","timestamp":1756810168221,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T00:00:00Z","timestamp":1468886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00e0 la Recherche dans l\u2019Industrie et dans l\u2019Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00018-016-2310-2","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T16:50:20Z","timestamp":1468947020000},"page":"4739-4748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases"],"prefix":"10.1007","volume":"73","author":[{"given":"Lorraine","family":"Springuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Losdyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Saussoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Turcq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois-Xavier","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Knoops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Renauld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"issue":"7239","key":"2310_CR1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458(7239):719\u2013724","journal-title":"Nature"},{"issue":"8","key":"2310_CR2","first-page":"3230","volume":"61","author":"LA Loeb","year":"2001","unstructured":"Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61(8):3230\u20133239","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"2310_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10555-013-9426-8","volume":"32","author":"EJ Fox","year":"2013","unstructured":"Fox EJ, Prindle MJ, Loeb LA (2013) Do mutator mutations fuel tumorigenesis? Cancer Metastasis Rev 32(3\u20134):353\u2013361","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"2310_CR4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1182\/blood.V100.3.1014","volume":"100","author":"C Roche-Lestienne","year":"2002","unstructured":"Roche-Lestienne C, Soenen-Cornu V, Grardel-Duflos N et al (2002) Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. Blood 100(3):1014\u20131018","journal-title":"Blood"},{"issue":"10","key":"2310_CR5","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1158\/0008-5472.CAN-07-6544","volume":"68","author":"W Bodmer","year":"2008","unstructured":"Bodmer W, Bielas JH, Beckman RA (2008) Genetic instability is not a requirement for tumor development. Cancer Res 68(10):3558\u20133560 (discussion 3560\u20133551)","journal-title":"Cancer Res"},{"issue":"5","key":"2310_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrm1907","volume":"7","author":"J Jiricny","year":"2006","unstructured":"Jiricny J (2006) The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7(5):335\u2013346","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2310_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/carcin\/18.1.1","volume":"18","author":"WE Glaab","year":"1997","unstructured":"Glaab WE, Tindall KR (1997) Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 18(1):1\u20138","journal-title":"Carcinogenesis"},{"issue":"2\u20133","key":"2310_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mrrev.2009.07.001","volume":"682","author":"CP Spampinato","year":"2009","unstructured":"Spampinato CP, Gomez RL, Galles C et al (2009) From bacteria to plants: a compendium of mismatch repair assays. Mutat Res 682(2\u20133):110\u2013128","journal-title":"Mutat Res"},{"issue":"3","key":"2310_CR9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3878","volume":"15","author":"HT Lynch","year":"2015","unstructured":"Lynch HT, Snyder CL, Shaw TG et al (2015) Milestones of Lynch syndrome: 1895\u20132015. Nat Rev Cancer 15(3):181\u2013194","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2310_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/carcin\/bgi298","volume":"27","author":"V O\u2019Brien","year":"2006","unstructured":"O\u2019Brien V, Brown R (2006) Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27(4):682\u2013692","journal-title":"Carcinogenesis"},{"issue":"11","key":"2310_CR11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/carcin\/19.11.1931","volume":"19","author":"WE Glaab","year":"1998","unstructured":"Glaab WE, Risinger JI, Umar A et al (1998) Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus. Carcinogenesis 19(11):1931\u20131937","journal-title":"Carcinogenesis"},{"issue":"6429","key":"2310_CR12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/363558a0","volume":"363","author":"Y Ionov","year":"1993","unstructured":"Ionov Y, Peinado MA, Malkhosyan S et al (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363(6429):558\u2013561","journal-title":"Nature"},{"issue":"12","key":"2310_CR13","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","volume":"95","author":"JG Herman","year":"1998","unstructured":"Herman JG, Umar A, Polyak K et al (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95(12):6870\u20136875","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2310_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/8.4.661","volume":"8","author":"SB Simpkins","year":"1999","unstructured":"Simpkins SB, Bocker T, Swisher EM et al (1999) MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 8(4):661\u2013666","journal-title":"Hum Mol Genet"},{"issue":"23","key":"2310_CR15","first-page":"6796","volume":"62","author":"A Hartmann","year":"2002","unstructured":"Hartmann A, Zanardo L, Bocker-Edmonston T et al (2002) Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res 62(23):6796\u20136802","journal-title":"Cancer Res"},{"issue":"37","key":"2310_CR16","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1038\/sj.onc.1205695","volume":"21","author":"L Gu","year":"2002","unstructured":"Gu L, Cline-Brown B, Zhang F et al (2002) Mismatch repair deficiency in hematological malignancies with microsatellite instability. Oncogene 21(37):5758\u20135764","journal-title":"Oncogene"},{"issue":"1","key":"2310_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9440(10)64349-0","volume":"160","author":"LL Siu","year":"2002","unstructured":"Siu LL, Chan JK, Wong KF et al (2002) Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol 160(1):59\u201366","journal-title":"Am J Pathol"},{"issue":"1","key":"2310_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/carcin\/24.1.31","volume":"24","author":"EC Matheson","year":"2003","unstructured":"Matheson EC, Hall AG (2003) Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia. Carcinogenesis 24(1):31\u201338","journal-title":"Carcinogenesis"},{"issue":"2","key":"2310_CR19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/cr.2008.14","volume":"18","author":"G Mao","year":"2008","unstructured":"Mao G, Yuan F, Absher K et al (2008) Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukemia: potential contribution to AML progression. Cell Res 18(2):281\u2013289","journal-title":"Cell Res"},{"issue":"7","key":"2310_CR20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/epi.5.7.12558","volume":"5","author":"EA Griffiths","year":"2010","unstructured":"Griffiths EA, Gore SD, Hooker CM et al (2010) Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia. Epigenetics 5(7):590\u2013600","journal-title":"Epigenetics"},{"issue":"5","key":"2310_CR21","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1182\/blood.V89.5.1740","volume":"89","author":"A Hangaishi","year":"1997","unstructured":"Hangaishi A, Ogawa S, Mitani K et al (1997) Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines. Blood 89(5):1740\u20131747","journal-title":"Blood"},{"issue":"2","key":"2310_CR22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.20259","volume":"78","author":"H Morimoto","year":"2005","unstructured":"Morimoto H, Tsukada J, Kominato Y et al (2005) Reduced expression of human mismatch repair genes in adult T-cell leukemia. Am J Hematol 78(2):100\u2013107","journal-title":"Am J Hematol"},{"issue":"26","key":"2310_CR23","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood-2014-05-576652","volume":"124","author":"L Springuel","year":"2014","unstructured":"Springuel L, Hornakova T, Losdyck E et al (2014) Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors. Blood 124(26):3924\u20133931","journal-title":"Blood"},{"issue":"11","key":"2310_CR24","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","volume":"19","author":"C Smet De","year":"1999","unstructured":"De Smet C, Lurquin C, Lethe B et al (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19(11):7327\u20137335","journal-title":"Mol Cell Biol"},{"issue":"18","key":"2310_CR25","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.85.18.6934","volume":"85","author":"C Uyttenhove","year":"1988","unstructured":"Uyttenhove C, Simpson RJ, Van Snick J (1988) Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci USA 85(18):6934\u20136938","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2310_CR26","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.4049\/jimmunol.154.10.5061","volume":"154","author":"J Louahed","year":"1995","unstructured":"Louahed J, Kermouni A, Van Snick J et al (1995) IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J Immunol 154(10):5061\u20135070","journal-title":"J Immunol"},{"issue":"4","key":"2310_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/gcc.22141","volume":"53","author":"AK Bergmann","year":"2014","unstructured":"Bergmann AK, Schneppenheim S, Seifert M et al (2014) Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer 53(4):309\u2013316","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"2310_CR28","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-03-559542","volume":"124","author":"MJ Kiel","year":"2014","unstructured":"Kiel MJ, Velusamy T, Rolland D et al (2014) Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood 124(9):1460\u20131472","journal-title":"Blood"},{"issue":"3","key":"2310_CR29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1073\/pnas.0912629107","volume":"107","author":"M Lynch","year":"2010","unstructured":"Lynch M (2010) Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci USA 107(3):961\u2013968","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"2310_CR30","doi-asserted-by":"crossref","first-page":"E2774","DOI":"10.1073\/pnas.1210309109","volume":"109","author":"H Lee","year":"2012","unstructured":"Lee H, Popodi E, Tang H et al (2012) Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. Proc Natl Acad Sci USA 109(41):E2774\u2013E2783","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2310_CR31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/gbe\/evu284","volume":"7","author":"H Long","year":"2014","unstructured":"Long H, Sung W, Miller SF et al (2014) Mutation rate, spectrum, topology, and context-dependency in the DNA mismatch repair-deficient Pseudomonas fluorescens ATCC948. Genome Biol Evol 7(1):262\u2013271","journal-title":"Genome Biol Evol"},{"issue":"9","key":"2310_CR32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djk150","volume":"99","author":"X Jiang","year":"2007","unstructured":"Jiang X, Saw KM, Eaves A et al (2007) Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells. J Natl Cancer Inst 99(9):680\u2013693","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2310_CR33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/leu.2010.179","volume":"24","author":"H Grant","year":"2010","unstructured":"Grant H, Jiang X, Stebbing J et al (2010) Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype. Leukemia 24(10):1817\u20131821","journal-title":"Leukemia"},{"issue":"2","key":"2310_CR34","doi-asserted-by":"crossref","first-page":"e55717","DOI":"10.1371\/journal.pone.0055717","volume":"8","author":"Z Iqbal","year":"2013","unstructured":"Iqbal Z, Aleem A, Iqbal M et al (2013) Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+\u00a0cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era. PLoS One 8(2):e55717","journal-title":"PLoS One"},{"issue":"20","key":"2310_CR35","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2012-11-466938","volume":"121","author":"E Bolton-Gillespie","year":"2013","unstructured":"Bolton-Gillespie E, Schemionek M, Klein HU et al (2013) Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells. Blood 121(20):4175\u20134183","journal-title":"Blood"},{"issue":"7","key":"2310_CR36","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J et al (2010) Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 120(7):2254\u20132264","journal-title":"J Clin Invest"},{"issue":"6","key":"2310_CR37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/leu.2010.67","volume":"24","author":"BA Burke","year":"2010","unstructured":"Burke BA, Carroll M (2010) BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia. Leukemia 24(6):1105\u20131112","journal-title":"Leukemia"},{"issue":"4","key":"2310_CR38","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","volume":"105","author":"JH Kim","year":"2005","unstructured":"Kim JH, Chu SC, Gramlich JL et al (2005) Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 105(4):1717\u20131723","journal-title":"Blood"},{"issue":"1","key":"2310_CR39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","volume":"108","author":"M Koptyra","year":"2006","unstructured":"Koptyra M, Falinski R, Nowicki MO et al (2006) BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 108(1):319\u2013327","journal-title":"Blood"},{"issue":"32","key":"2310_CR40","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","volume":"275","author":"M Sattler","year":"2000","unstructured":"Sattler M, Verma S, Shrikhande G et al (2000) The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 275(32):24273\u201324278","journal-title":"J Biol Chem"},{"issue":"8","key":"2310_CR41","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-07-6858","volume":"68","author":"T Stoklosa","year":"2008","unstructured":"Stoklosa T, Poplawski T, Koptyra M et al (2008) BCR\/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations. Cancer Res 68(8):2576\u20132580","journal-title":"Cancer Res"},{"issue":"12","key":"2310_CR42","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood-2007-03-080838","volume":"110","author":"J Cortes","year":"2007","unstructured":"Cortes J, Jabbour E, Kantarjian H et al (2007) Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors. Blood 110(12):4005\u20134011","journal-title":"Blood"},{"issue":"9","key":"2310_CR43","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1172\/JCI30890","volume":"117","author":"NP Shah","year":"2007","unstructured":"Shah NP, Skaggs BJ, Branford S et al (2007) Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency. J Clin Invest 117(9):2562\u20132569","journal-title":"J Clin Invest"},{"issue":"10","key":"2310_CR44","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1182\/blood-2009-01-197186","volume":"114","author":"S Soverini","year":"2009","unstructured":"Soverini S, Gnani A, Colarossi S et al (2009) Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors. Blood 114(10):2168\u20132171","journal-title":"Blood"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2310-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-016-2310-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2310-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T07:47:16Z","timestamp":1692431236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-016-2310-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":44,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2310"],"URL":"https:\/\/doi.org\/10.1007\/s00018-016-2310-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"type":"print","value":"1420-682X"},{"type":"electronic","value":"1420-9071"}],"subject":[],"published":{"date-parts":[[2016,7,19]]}}}